Citigroup »

Merrimack Pharma shares owned by Citigroup

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 1.6k 13.41
2023-09-30 $295 24 12.32
2019-06-30 $3.0k 449 6.68
2019-03-31 $42k 6.3k 6.68
2018-12-31 $34k 8.9k 3.81
2018-09-30 $15k 2.9k 5.19
2018-06-30 $51k 10k 5.01
2018-03-31 $49k 6.0k 8.09
2017-12-31 $84k 8.3k 10.14
2017-09-30 $101k 6.9k 14.67